
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Vicebio uses the molecular clamp technology to develop innovative vaccines against life-threatening respiratory viruses. The Molecular Clamp technology provide unique stabilisation of viral envelop glycoproteins making possible highly effective, ready-to-use, and multivalent single shot respiratory virus vaccines
Vaccines,structural vaccinology,respiratory viruses,rsv,influenza,sars-cov-2,metapneumovirus,and parainfluenza
Vicebio operates in the Biotechnology research industry.
Vicebio's revenue is 11m - 100m
Vicebio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.